Hantz O, Allaudeen H S, Ooka T, De Clercq E, Trepo C
Antiviral Res. 1984 Aug;4(4):187-99. doi: 10.1016/0166-3542(84)90017-2.
The triphosphates of acyclovir (ACV), 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine (FIAC) and E-5-(2-bromovinyl)-2'-deoxyuridine (BVdU) have been examined for their inhibitory effects on the endogenous DNA polymerase reactions of human hepatitis B virus (HBV) and woodchuck hepatitis virus (WHV). All three triphosphates (ACVTP, FIACTP and BVdUTP) inhibited the HBV and WHV DNA polymerases by competing with the corresponding natural substrates. FIACTP was the most potent inhibitor of HBV and WHV DNA polymerase while ACVTP was the least effective inhibitor. The inhibitory properties of these compounds were compared with those of the 5'-triphosphates of 1-beta-arabinofuranosyl-cytosine (ara-CTP) and 1-beta-arabinofuranosylthymine (ara-TTP). The 50% inhibitory doses for HBV and WHV DNA polymerases were in the following order: FIACTP less than BVdUTP less than ara-TTP less than ACVTP less than ara-CTP. BVdUTP appeared to be an efficient alternate substrate to dTTP for HBV DNA polymerase while FIACTP was much less efficient when substituted for dCTP. ACVTP did not act as an alternate substrate to dGTP and appeared to prevent DNA chain elongation.
已对阿昔洛韦(ACV)、1-(2'-脱氧-2'-氟-β-D-阿拉伯呋喃糖基)-5-碘胞嘧啶(FIAC)和E-5-(2-溴乙烯基)-2'-脱氧尿苷(BVdU)的三磷酸酯对人乙型肝炎病毒(HBV)和土拨鼠肝炎病毒(WHV)内源性DNA聚合酶反应的抑制作用进行了研究。所有这三种三磷酸酯(ACVTP、FIACTP和BVdUTP)均通过与相应的天然底物竞争来抑制HBV和WHV DNA聚合酶。FIACTP是HBV和WHV DNA聚合酶最有效的抑制剂,而ACVTP是效果最差的抑制剂。将这些化合物的抑制特性与1-β-阿拉伯呋喃糖基胞嘧啶(ara-CTP)和1-β-阿拉伯呋喃糖基胸腺嘧啶(ara-TTP)的5'-三磷酸酯的抑制特性进行了比较。HBV和WHV DNA聚合酶的50%抑制剂量顺序如下:FIACTP<BVdUTP<ara-TTP<ACVTP<ara-CTP。BVdUTP似乎是HBV DNA聚合酶替代dTTP的有效底物,而FIACTP替代dCTP时效率要低得多。ACVTP不作为dGTP的替代底物,似乎会阻止DNA链延伸。